Compendium of Cancer Genome Aberrations

Bailey.Glen

Joined 17 December 2021
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 12: Line 12:
|-
|-


|[[BRST5:Usual_ductal_hyperplasia|Usual ductal hyperplasia]]
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
|Disease
|Disease
|
|
Line 23: Line 23:
|
|
|-
|-
|[[BRST5:Columnar_cell_lesions,_including_flat_epithelial_atypia_|Columnar cell lesions, including flat epithelial atypia ]]
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Disease
|
|
Line 34: Line 34:
|
|
|-
|-
|[[BRST5:Atypical_ductal_hyperplasia|Atypical ductal hyperplasia]]
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|Disease
|Disease
|
|
Line 45: Line 45:
|
|
|-
|-
|[[BRST5:Sclerosing_adenosis|Sclerosing adenosis]]
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
|Disease
|Disease
|
|
Line 56: Line 56:
|
|
|-
|-
|[[BRST5:Apocrine_adenosis_and_adenoma|Apocrine adenosis and adenoma]]
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
|Disease
|Disease
|
|
Line 67: Line 67:
|
|
|-
|-
|[[BRST5:Microglandular_adenosis_|Microglandular adenosis ]]
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
|Disease
|Disease
|
|
Line 78: Line 78:
|
|
|-
|-
|[[BRST5:Radial_scar_/_complex_sclerosing_lesion_|Radial scar / complex sclerosing lesion ]]
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered ]]
|Disease
|Disease
|
|
Line 89: Line 89:
|
|
|-
|-
|[[BRST5:Tubular_adenoma_|Tubular adenoma ]]
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|Disease
|Disease
|
|
Line 100: Line 100:
|
|
|-
|-
|[[BRST5:Lactating_adenoma_|Lactating adenoma ]]
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
|Disease
|Disease
|
|
Line 111: Line 111:
|
|
|-
|-
|[[BRST5:Ductal_adenoma|Ductal adenoma]]
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
|Disease
|Disease
|
|
Line 122: Line 122:
|
|
|-
|-
|[[BRST5:Pleomorphic_adenoma|Pleomorphic adenoma]]
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
|Disease
|Disease
|
|
Line 133: Line 133:
|
|
|-
|-
|[[BRST5:Adenomyoepithelioma|Adenomyoepithelioma]]
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma ]]
|Disease
|Disease
|
|
Line 144: Line 144:
|
|
|-
|-
|[[BRST5:Malignant_adenomyoepithelioma|Malignant adenomyoepithelioma]]
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|Disease
|Disease
|
|
Line 155: Line 155:
|
|
|-
|-
|[[BRST5:Intraductal_papilloma|Intraductal papilloma]]
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|Disease
|Disease
|
|
Line 166: Line 166:
|
|
|-
|-
|[[BRST5:Papillary_ductal_carcinoma_in_situ|Papillary ductal carcinoma in situ]]
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
|Disease
|Disease
|
|
Line 177: Line 177:
|
|
|-
|-
|[[BRST5:Encapsulated_papillary_carcinoma|Encapsulated papillary carcinoma]]
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
|Disease
|Disease
|
|
Line 188: Line 188:
|
|
|-
|-
|[[BRST5:Solid_papillary_carcinoma_(in_situ_and_invasive)|Solid papillary carcinoma (in situ and invasive)]]
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|Disease
|Disease
|
|
Line 199: Line 199:
|
|
|-
|-
|[[BRST5:Invasive_papillary_carcinoma|Invasive papillary carcinoma]]
|[[CNS5:Ganglioglioma|Ganglioglioma]]
|Disease
|Disease
|
|
Line 210: Line 210:
|
|
|-
|-
|[[BRST5:Atypical_lobular_hyperplasia_|Atypical lobular hyperplasia ]]
|[[CNS5:Gangliocytoma|Gangliocytoma]]
|Disease
|Disease
|
|
Line 221: Line 221:
|
|
|-
|-
|[[BRST5:Lobular_carcinoma_in_situ|Lobular carcinoma in situ]]
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
|Disease
|Disease
|
|
Line 232: Line 232:
|
|
|-
|-
|[[BRST5:Ductal_carcinoma_in_situ_|Ductal carcinoma in situ ]]
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
|Disease
|Disease
|
|
Line 243: Line 243:
|
|
|-
|-
|[[BRST5:Invasive_breast_carcinoma:_General_overview|Invasive breast carcinoma: General overview]]
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
|Disease
|Disease
|
|
Line 254: Line 254:
|
|
|-
|-
|[[BRST5:Invasive_breast_carcinoma_of_no_special_type|Invasive breast carcinoma of no special type]]
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
|Disease
|Disease
|
|
Line 265: Line 265:
|
|
|-
|-
|[[BRST5:Microinvasive_carcinoma|Microinvasive carcinoma]]
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
|Disease
|Disease
|
|
Line 276: Line 276:
|
|
|-
|-
|[[BRST5:Invasive_lobular_carcinoma_|Invasive lobular carcinoma ]]
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
|Disease
|Disease
|
|
Line 287: Line 287:
|
|
|-
|-
|[[BRST5:Tubular_carcinoma|Tubular carcinoma]]
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|Disease
|Disease
|
|
Line 298: Line 298:
|
|
|-
|-
|[[BRST5:Cribriform_carcinoma|Cribriform carcinoma]]
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|Disease
|Disease
|
|
Line 309: Line 309:
|
|
|-
|-
|[[BRST5:Mucinous_carcinoma|Mucinous carcinoma]]
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
|Disease
|Disease
|
|
Line 320: Line 320:
|
|
|-
|-
|[[BRST5:Mucinous_cystadenocarcinoma|Mucinous cystadenocarcinoma]]
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
|Disease
|Disease
|
|
Line 331: Line 331:
|
|
|-
|-
|[[BRST5:Invasive_micropapillary_carcinoma|Invasive micropapillary carcinoma]]
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
|Disease
|Disease
|
|
Line 342: Line 342:
|
|
|-
|-
|[[BRST5:Carcinoma_with_apocrine_differentiation|Carcinoma with apocrine differentiation]]
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
|Disease
|Disease
|
|
Line 353: Line 353:
|
|
|-
|-
|[[BRST5:Metaplastic_carcinoma|Metaplastic carcinoma]]
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|Disease
|Disease
|
|
Line 364: Line 364:
|
|
|-
|-
|[[BRST5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive ]]
|Disease
|Disease
|
|
Line 375: Line 375:
|
|
|-
|-
|[[BRST5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|Disease
|Disease
|
|
Line 386: Line 386:
|
|
|-
|-
|[[BRST5:Secretory_carcinoma_|Secretory carcinoma ]]
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
|Disease
|Disease
|
|
Line 397: Line 397:
|
|
|-
|-
|[[BRST5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
|Disease
|Disease
|
|
Line 408: Line 408:
|
|
|-
|-
|[[BRST5:Polymorphous_adenocarcinoma|Polymorphous adenocarcinoma]]
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
|Disease
|Disease
|
|
Line 419: Line 419:
|
|
|-
|-
|[[BRST5:Tall_cell_carcinoma_with_reversed_polarity|Tall cell carcinoma with reversed polarity]]
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
|Disease
|Disease
|
|
Line 430: Line 430:
|
|
|-
|-
|[[BRST5:Neuroendocrine_tumour|Neuroendocrine tumour]]
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
|Disease
|Disease
|
|
Line 441: Line 441:
|
|
|-
|-
|[[BRST5:Neuroendocrine_carcinoma|Neuroendocrine carcinoma]]
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
|Disease
|Disease
|
|
Line 452: Line 452:
|
|
|-
|-
|[[BRST5:Hamartoma_|Hamartoma ]]
|[[CNS5:Subependymoma|Subependymoma]]
|Disease
|Disease
|
|
Line 463: Line 463:
|
|
|-
|-
|[[BRST5:Fibroadenoma_|Fibroadenoma ]]
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
|Disease
|Disease
|
|
Line 474: Line 474:
|
|
|-
|-
|[[BRST5:Phyllodes_tumour_|Phyllodes tumour ]]
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
|Disease
|Disease
|
|
Line 485: Line 485:
|
|
|-
|-
|[[BRST5:Syringomatous_tumour_|Syringomatous tumour ]]
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
|Disease
|Disease
|
|
Line 496: Line 496:
|
|
|-
|-
|[[BRST5:Nipple_adenoma_|Nipple adenoma ]]
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Disease
|
|
Line 507: Line 507:
|
|
|-
|-
|[[BRST5:Paget_disease_of_the_breast|Paget disease of the breast]]
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
|Disease
|Disease
|
|
Line 518: Line 518:
|
|
|-
|-
|[[BRST5:Haemangioma|Haemangioma]]
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|Disease
|
|
Line 529: Line 529:
|
|
|-
|-
|[[BRST5:Angiomatosis|Angiomatosis]]
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
|Disease
|Disease
|
|
Line 540: Line 540:
|
|
|-
|-
|[[BRST5:Atypical_vascular_lesions_|Atypical vascular lesions ]]
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
|Disease
|Disease
|
|
Line 551: Line 551:
|
|
|-
|-
|[[BRST5:Postradiation_angiosarcoma_of_the_breast|Postradiation angiosarcoma of the breast]]
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
|Disease
|Disease
|
|
Line 562: Line 562:
|
|
|-
|-
|[[BRST5:Primary_angiosarcoma_of_the_breast|Primary angiosarcoma of the breast]]
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
|Disease
|Disease
|
|
Line 573: Line 573:
|
|
|-
|-
|[[BRST5:Nodular_fasciitis|Nodular fasciitis]]
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
|Disease
|Disease
|
|
Line 584: Line 584:
|
|
|-
|-
|[[BRST5:Myofibroblastoma|Myofibroblastoma]]
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
|Disease
|Disease
|
|
Line 595: Line 595:
|
|
|-
|-
|[[BRST5:Desmoid_fibromatosis_|Desmoid fibromatosis ]]
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
|Disease
|Disease
|
|
Line 606: Line 606:
|
|
|-
|-
|[[BRST5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour ]]
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
|Disease
|Disease
|
|
Line 617: Line 617:
|
|
|-
|-
|[[BRST5:Schwannoma_|Schwannoma ]]
|[[CNS5:Pineocytoma|Pineocytoma]]
|Disease
|Disease
|
|
Line 628: Line 628:
|
|
|-
|-
|[[BRST5:Neurofibroma_|Neurofibroma ]]
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
|Disease
|Disease
|
|
Line 639: Line 639:
|
|
|-
|-
|[[BRST5:Granular_cell_tumour|Granular cell tumour]]
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|Disease
|
|
Line 650: Line 650:
|
|
|-
|-
|[[BRST5:Leiomyoma|Leiomyoma]]
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
|Disease
|Disease
|
|
Line 661: Line 661:
|
|
|-
|-
|[[BRST5:Leiomyosarcoma_|Leiomyosarcoma ]]
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
|Disease
|Disease
|
|
Line 672: Line 672:
|
|
|-
|-
|[[BRST5:Lipoma_|Lipoma ]]
|[[CNS5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|
Line 683: Line 683:
|
|
|-
|-
|[[BRST5:Angiolipoma_|Angiolipoma ]]
|[[CNS5:Neurofibroma|Neurofibroma]]
|Disease
|Disease
|
|
Line 694: Line 694:
|
|
|-
|-
|[[BRST5:Liposarcoma_|Liposarcoma ]]
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|Disease
|
|
Line 705: Line 705:
|
|
|-
|-
|[[BRST5:Pseudoangiomatous_stromal_hyperplasia|Pseudoangiomatous stromal hyperplasia]]
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|Disease
|Disease
|
|
Line 716: Line 716:
|
|
|-
|-
|[[BRST5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 727: Line 727:
|
|
|-
|-
|[[BRST5:Follicular_lymphoma_|Follicular lymphoma ]]
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|Disease
|
|
Line 738: Line 738:
|
|
|-
|-
|[[BRST5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma ]]
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|Disease
|Disease
|
|
Line 749: Line 749:
|
|
|-
|-
|[[BRST5:Burkitt_lymphoma|Burkitt lymphoma]]
|[[CNS5:Meningioma|Meningioma]]
|Disease
|Disease
|
|
Line 760: Line 760:
|
|
|-
|-
|[[BRST5:Breast_implant-associated_anaplastic_large_cell_lymphoma_|Breast implant-associated anaplastic large cell lymphoma ]]
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Disease
|
|
Line 771: Line 771:
|
|
|-
|-
|[[BRST5:Gynaecomastia|Gynaecomastia]]
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
|Disease
|Disease
|
|
Line 782: Line 782:
|
|
|-
|-
|[[BRST5:Carcinoma_in_situ|Carcinoma in situ]]
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
|Disease
|Disease
|
|
Line 793: Line 793:
|
|
|-
|-
|[[BRST5:Invasive_carcinoma|Invasive carcinoma]]
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 804: Line 804:
|
|
|-
|-
|[[BRST5:Metastases_to_the_breast|Metastases to the breast]]
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
|Disease
|Disease
|
|
Line 815: Line 815:
|
|
|-
|-
|[[BRST5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|Disease
|
|
Line 826: Line 826:
|
|
|-
|-
|[[BRST5:Cowden_syndrome|Cowden syndrome]]
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|Disease
|
|
Line 837: Line 837:
|
|
|-
|-
|[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Disease
|
|
Line 848: Line 848:
|
|
|-
|-
|[[BRST5:Li-Fraumeni_syndrome,_TP53-associated|Li-Fraumeni syndrome, TP53-associated]]
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|Disease
|
|
Line 859: Line 859:
|
|
|-
|-
|[[BRST5:Li-Fraumeni_syndrome,_CHEK2-associated|Li-Fraumeni syndrome, CHEK2-associated]]
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|Disease
|Disease
|
|
Line 870: Line 870:
|
|
|-
|-
|[[BRST5:CDH1-associated_breast_cancer|CDH1-associated breast cancer]]
|[[CNS5:Chordoma|Chordoma]]
|Disease
|Disease
|
|
Line 881: Line 881:
|
|
|-
|-
|[[BRST5:PALB2-associated_cancers|PALB2-associated cancers]]
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|Disease
|
|
Line 892: Line 892:
|
|
|-
|-
|[[BRST5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|Disease
|Disease
|
|
Line 903: Line 903:
|
|
|-
|-
|[[BRST5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
|Disease
|Disease
|
|
Retrieved from "https://test.ccga.io/index.php/User:Bailey.Glen"